Winterlight Labs

About:

Winterlight builds technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech.

Website: http://www.winterlightlabs.com/

Twitter/X: winterlightlabs

Top Investors: Creative Destruction Lab (CDL), First Star Ventures, Ontario Centres of Excellence, Pacific Health Ventures, Hikma Ventures

Description:

Winterlight Labs builds technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech. WinterLight Labs develops a novel AI technology platform that can quickly and accurately quantify speech and language patterns to help detect and monitor cognitive and mental diseases. This platform can analyze natural speech to detect and monitor dementia, aphasia, and various cognitive conditions. Using a short one-minute sample of speech, WinterLight can characterize the speaker's cognitive, acoustic, and linguistic state, including lexical diversity, syntactic complexity, semantic content, and articulation. Winterlight was founded in 2015 and is based in Toronto, Canada.

Total Funding Amount:

$5.23M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2015-01-01

Founders:

Frank Rudzicz, Kathleen Fraser, Liam Kaufman, Maria Yancheva

Number of Employees:

11-50

Last Funding Date:

2019-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai